River & Mercantile Asset Management LLP bought a new stake in shares of Transcat, Inc. (NASDAQ:TRNS) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 52,064 shares of the scientific and technical instruments company’s stock, valued at approximately $1,332,000. River & Mercantile Asset Management LLP owned about 0.71% of Transcat at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the stock. Ancora Advisors LLC lifted its position in Transcat by 22.0% in the second quarter. Ancora Advisors LLC now owns 268,160 shares of the scientific and technical instruments company’s stock worth $6,862,000 after purchasing an additional 48,368 shares during the period. Hillsdale Investment Management Inc. acquired a new stake in shares of Transcat during the second quarter worth approximately $102,000. Oppenheimer Asset Management Inc. increased its holdings in shares of Transcat by 112.9% during the second quarter. Oppenheimer Asset Management Inc. now owns 5,788 shares of the scientific and technical instruments company’s stock worth $148,000 after buying an additional 3,069 shares in the last quarter. Renaissance Technologies LLC increased its holdings in shares of Transcat by 69.1% during the second quarter. Renaissance Technologies LLC now owns 76,586 shares of the scientific and technical instruments company’s stock worth $1,960,000 after buying an additional 31,300 shares in the last quarter. Finally, Russell Investments Group Ltd. increased its holdings in shares of Transcat by 437.7% during the second quarter. Russell Investments Group Ltd. now owns 64,888 shares of the scientific and technical instruments company’s stock worth $1,660,000 after buying an additional 52,820 shares in the last quarter. 65.00% of the stock is owned by institutional investors and hedge funds.

A number of analysts recently weighed in on TRNS shares. Zacks Investment Research raised shares of Transcat from a “sell” rating to a “hold” rating in a report on Thursday, September 26th. ValuEngine lowered shares of Transcat from a “buy” rating to a “hold” rating in a report on Thursday, August 1st.

TRNS stock traded down $2.85 during midday trading on Wednesday, reaching $23.14. The company’s stock had a trading volume of 253 shares, compared to its average volume of 31,474. Transcat, Inc. has a 52 week low of $17.56 and a 52 week high of $27.41. The stock has a market cap of $189.59 million, a PE ratio of 24.36, a price-to-earnings-growth ratio of 3.53 and a beta of 0.81. The company has a quick ratio of 1.38, a current ratio of 2.10 and a debt-to-equity ratio of 0.44. The business’s 50-day simple moving average is $23.52 and its 200-day simple moving average is $24.08.

Transcat (NASDAQ:TRNS) last announced its quarterly earnings results on Tuesday, July 23rd. The scientific and technical instruments company reported $0.23 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.02). The firm had revenue of $42.40 million for the quarter. Transcat had a return on equity of 12.84% and a net margin of 4.46%. As a group, equities analysts forecast that Transcat, Inc. will post 0.92 earnings per share for the current fiscal year.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

See Also: Retained Earnings

Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS).

Institutional Ownership by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.